BioSig Technologies, Inc. announced a subscription model for its PURE EP?? Platform. Cleveland Clinic--recent recently ranked as number one in the Nation for cardiology, heart & vascular surgery by U.S. News & World Report--is first to sign an agreement to acquire the PURE EP??

Platform under the subscription model. BioSig has made the move to a subscription model so that electrophysiologists and cardiology departments can access the latest features with the ability to customize the rich suite of PURE EP?? software capabilities to suit their needs.

The proprietary combination of hardware and software empowers electrophysiologists with real-time, ultra-pure, cardiac signal data, with the potential to improve arrhythmia care and procedures. The agreement follows BioSig's exhibition at the Heart Rhythm Society 2023 ("HRS 2023") in May, known for being the largest gathering of heart rhythm professionals worldwide. During the conference, research conceptualized and spearheaded by Cleveland Clinic's world-class physician faculty highlighted the PURE EP??

platform's ability to optimize ablation procedures. With a comprehensive suite of tools available through the subscription model, the PURE EP?? platforms can deliver the latest developments in electrophysiologists to physicians as they emerge, with the flexibility to add enhancements as desired.